corneat.com
About company
CorNeat Vision is an innovative ophthalmic medical device company with an overarching mission of promoting human health, sustainability and equality worldwide. CorNeat Vision’s patented implants and corresponding procedures prevent and reverse blinding disease processes by mending and replacing damaged tissue, while mimicking its function. The CorNeat Vision lineup of biomimetic ophthalmic implants blend novel bio-integration technology with innovative ideas to create groundbreaking solutions that address unmet ophthalmic needs. Our products biomechanically incorporate with resident ocular tissue providing safe, aesthetic and long-lasting remedies for corneally blind patients and those suffering from severe glaucoma. These include the CorNeat KPro (artificial cornea), the CorNeat EverPatch (synthetic non-degradable scleral patch) and the CorNeat eShunt (Glaucoma drainage device). In July 2020, the company received approval to begin a clinical trial at Beilinson Hospital, Israel, for its CorNeat KPro.
